Literature DB >> 27586378

Advanced Vulvar Cancers: What are the Best Options for Treatment?

Alejandro Soderini1, Alejandro Aragona2, Nicholas Reed3.   

Abstract

The treatment of patients with vulvar cancer remains challenging for gynecologic oncologists. Up to 30 % of the cases are diagnosed in a clinical condition of irresectability, and some kind of strategy has to be taken into account beyond surgery. In this regard, a common and standard definition is critical to maximize oncological results and minimize complications after treatments. Each patient treatment must be tailored individually according to their clinical and biological features and to the setting in which they are dealing with.

Entities:  

Keywords:  Chemoradiation; Neoadjuvant chemotherapy; Radical surgery; Vulvar cancer

Mesh:

Year:  2016        PMID: 27586378     DOI: 10.1007/s11912-016-0545-6

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN: 1523-3790            Impact factor:   5.075


  32 in total

1.  Long-term follow-up of the first randomized trial using neoadjuvant chemotherapy in stage Ib squamous carcinoma of the cervix: the final results.

Authors:  J E Sardi; A Giaroli; C Sananes; M Ferreira; A Soderini; A Bermudez; L Snaidas; S Vighi; N Gomez Rueda; G di Paola
Journal:  Gynecol Oncol       Date:  1997-10       Impact factor: 5.482

2.  A possible new trend in the management of the carcinoma of the cervix uteri.

Authors:  J E Sardi; G R di Paola; A Cachau; O C Ortiz; C Sananes; A Giaroli; D Martins; M Peluffo
Journal:  Gynecol Oncol       Date:  1986-10       Impact factor: 5.482

3.  Trends in the incidence of invasive and in situ vulvar carcinoma.

Authors:  Patricia L Judson; Elizabeth B Habermann; Nancy N Baxter; Sara B Durham; Beth A Virnig
Journal:  Obstet Gynecol       Date:  2006-05       Impact factor: 7.661

4.  The benefit of adjuvant radiation therapy in single-node-positive squamous cell vulvar carcinoma.

Authors:  Anand Parthasarathy; Michael K Cheung; Kathryn Osann; Amreen Husain; Nelson N Teng; Jonathan S Berek; Daniel S Kapp; John K Chan
Journal:  Gynecol Oncol       Date:  2006-08-04       Impact factor: 5.482

5.  Neoadjuvant chemotherapy in locally advanced carcinoma of the cervix uteri.

Authors:  J Sardi; C Sananes; A Giaroli; G Maya; G di Paola
Journal:  Gynecol Oncol       Date:  1990-09       Impact factor: 5.482

6.  Margin distance and other clinico-pathologic prognostic factors in vulvar carcinoma: a multivariate analysis.

Authors:  John K Chan; Valerie Sugiyama; Huyen Pham; Mai Gu; Joanne Rutgers; Kathryn Osann; Michael K Cheung; Michael L Berman; Philip J Disaia
Journal:  Gynecol Oncol       Date:  2006-11-07       Impact factor: 5.482

7.  Cisplatin (P), bleomycin (B), and methotrexate (M) preoperative chemotherapy in locally advanced vulvar carcinoma.

Authors:  P Benedetti-Panici; S Greggi; G Scambia; G Salerno; S Mancuso
Journal:  Gynecol Oncol       Date:  1993-07       Impact factor: 5.482

8.  Tailoring the treatment of locally advanced squamous cell carcinoma of the vulva: neoadjuvant chemotherapy followed by radical surgery: results from a multicenter study.

Authors:  Alejandro M Aragona; Nicasio Cuneo; Alejandro H Soderini; Elsa Alcoba; Adriana Greco; Carlos Reyes; Silvia Lekmann
Journal:  Int J Gynecol Cancer       Date:  2012-09       Impact factor: 3.437

9.  Role of paclitaxel and cisplatin as the neoadjuvant treatment for locally advanced squamous cell carcinoma of the vulva.

Authors:  Francesco Raspagliesi; Flavia Zanaboni; Fabio Martinelli; Santiago Scasso; Joel Laufer; Antonino Ditto
Journal:  J Gynecol Oncol       Date:  2014-01-08       Impact factor: 4.401

10.  Defining the concept of locally advanced squamous cell carcinoma of the vulva: a new perspective based on standardization of criteria and current evidence.

Authors:  Alejandro M Aragona; Alejandro H Soderini; Nicasio A Cuneo
Journal:  J Gynecol Oncol       Date:  2014-07-06       Impact factor: 4.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.